Key Record Dates
ClinicalTrials.gov Identifier: | NCT03536559 |
---|---|
Brief Title: | Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (VISIONARY-MS) |
First Submitted : | May 2, 2018 |
First Submitted that Met QC Criteria : | May 14, 2018 |
First Posted : | May 24, 2018 |
Last Update Submitted that Met QC Criteria : | August 10, 2022 |
Last Update Posted : | August 12, 2022 |